<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Tandem Diabetes Care Inc — News on 6ix</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc</link>
<description>Latest news and press releases for Tandem Diabetes Care Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 27 Apr 2026 13:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/tandem-diabetes-care-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835cc0278dffbe2df11d66f.webp</url>
<title>Tandem Diabetes Care Inc</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc</link>
</image>
<item>
<title>Tandem Diabetes Care’s Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-cares-control-iq-automated-insulin-delivery-technology-now-fda-cleared-for-pregnancy-in-type-1-diabetes</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-cares-control-iq-automated-insulin-delivery-technology-now-fda-cleared-for-pregnancy-in-type-1-diabetes</guid>
<pubDate>Mon, 27 Apr 2026 13:00:00 GMT</pubDate>
<description>SAN DIEGO, April 27, 2026--FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type 1 diabetes.</description>
</item>
<item>
<title>Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-to-announce-first-quarter-2026-financial-results-on-may-7-2026</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-to-announce-first-quarter-2026-financial-results-on-may-7-2026</guid>
<pubDate>Thu, 02 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN DIEGO, April 02, 2026--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2026 results after the financial markets close on Thursday, May 7, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2026 financial and operating results.</description>
</item>
<item>
<title>Tandem Mobi Now Compatible with Android Smartphones</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-mobi-now-compatible-with-android-smartphones-16</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-mobi-now-compatible-with-android-smartphones-16</guid>
<pubDate>Wed, 04 Mar 2026 05:00:00 GMT</pubDate>
<description>Tandem Diabetes Care expands connected-care ecosystem by adding Android platform SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a</description>
</item>
<item>
<title>Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-prices-upsized-private-placement-of-dollar265-million-of-convertible-senior-notes-due-2032</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-prices-upsized-private-placement-of-dollar265-million-of-convertible-senior-notes-due-2032</guid>
<pubDate>Wed, 25 Feb 2026 05:30:00 GMT</pubDate>
<description>SAN DIEGO, February 25, 2026--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today the pricing of $265.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the "notes") in a private placement (the "offering") to persons reasonably believed to be qualified institutional buyers under Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering was upsized from the previously</description>
</item>
<item>
<title>Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-fourth-quarter-and-full-year-2025-financial-results-and-2026-financial-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-fourth-quarter-and-full-year-2025-financial-results-and-2026-financial-guidance</guid>
<pubDate>Thu, 19 Feb 2026 21:05:00 GMT</pubDate>
<description>SAN DIEGO, February 19, 2026--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2025 and provided its financial guidance for the year ending December 31, 2026.</description>
</item>
<item>
<title>Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announce-fourth-210500353</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announce-fourth-210500353</guid>
<pubDate>Thu, 08 Jan 2026 21:05:00 GMT</pubDate>
<description>SAN DIEGO, January 08, 2026--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2025 results after the financial markets close on Thursday, February 19, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its fourth quarter and full year 2025 financial and operating results.</description>
</item>
<item>
<title>Tandem t:slim Mobile App Now Available in Canada</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-t-slim-mobile-app-now-available-canada-2025-12-18</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-t-slim-mobile-app-now-available-canada-2025-12-18</guid>
<pubDate>Thu, 18 Dec 2025 05:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) a leading insulin delivery and diabetes technology company, today announced</description>
</item>
<item>
<title>Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-appointment-sandra-beaver-board-directors-2025-11-12</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-appointment-sandra-beaver-board-directors-2025-11-12</guid>
<pubDate>Wed, 12 Nov 2025 05:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the</description>
</item>
<item>
<title>Tandem Mobi Receives FDA Clearance for Use with Android Smartphones</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-mobi-receives-fda-clearance-use-android-smartphones-2025-11-10</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-mobi-receives-fda-clearance-use-android-smartphones-2025-11-10</guid>
<pubDate>Mon, 10 Nov 2025 05:00:00 GMT</pubDate>
<description>By adding compatibility with the Android platform, Tandem Mobi is expanding its connected-care ecosystem SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care,</description>
</item>
<item>
<title>Tandem Diabetes Care Announces Third Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-third-quarter-2025-financial-results-2025-11-06</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-third-quarter-2025-financial-results-2025-11-06</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its</description>
</item>
<item>
<title>Tandem Diabetes Care Achieves ISO/IEC 27001:2022 Certification, Reinforcing Commitment to Global Data Security Standards</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-achieves-iso-iec-27001-2022-certification-reinforcing-commitment</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-achieves-iso-iec-27001-2022-certification-reinforcing-commitment</guid>
<pubDate>Tue, 04 Nov 2025 05:00:00 GMT</pubDate>
<description>Certification affirms Tandem’s company-wide commitment to cybersecurity, data protection, and operational integrity SAN DIEGO--(BUSINESS WIRE)-- Tandem</description>
</item>
<item>
<title>Tandem Diabetes Care Announces Upcoming Conference Presentations</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-upcoming-conference-presentations-2025-10-31</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-upcoming-conference-presentations-2025-10-31</guid>
<pubDate>Fri, 31 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that</description>
</item>
<item>
<title>t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/t-slim-x2tm-insulin-pump-now-available-abbotts-freestyle-librer-3-plus-sensor-united</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/t-slim-x2tm-insulin-pump-now-available-abbotts-freestyle-librer-3-plus-sensor-united</guid>
<pubDate>Wed, 29 Oct 2025 04:00:00 GMT</pubDate>
<description>Tandem Diabetes Care begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and</description>
</item>
<item>
<title>Tandem Diabetes Care to Announce Third Quarter 2025 Financial Results on November 6, 2025</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announce-third-quarter-2025-financial-results-november-6-2025</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announce-third-quarter-2025-financial-results-november-6-2025</guid>
<pubDate>Thu, 02 Oct 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its</description>
</item>
<item>
<title>Tandem t:slim X2 Insulin Pump Now Compatible With Lyumjev Ultra-Rapid Acting Insulin in the United States</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-t-slim-x2-insulin-pump-now-compatible-lyumjev-ultra-rapid-acting-insulin</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-t-slim-x2-insulin-pump-now-compatible-lyumjev-ultra-rapid-acting-insulin</guid>
<pubDate>Mon, 29 Sep 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its</description>
</item>
<item>
<title>Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-publication-showing-adults-type-2-diabetes-benefit</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-publication-showing-adults-type-2-diabetes-benefit</guid>
<pubDate>Tue, 16 Sep 2025 04:00:00 GMT</pubDate>
<description>This sub-analysis is the first study to evaluate AID outcomes for people with type 2 diabetes using the Center for Medicare and Medicaid Services (CMS)</description>
</item>
<item>
<title>Tandem t:slim Mobile App Now Authorized by Health Canada for iPhone and Android Phones</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-t-slim-mobile-app-now-authorized-health-canada-iphone-and-android-phones-2025</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-t-slim-mobile-app-now-authorized-health-canada-iphone-and-android-phones-2025</guid>
<pubDate>Thu, 04 Sep 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced Health</description>
</item>
<item>
<title>Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-issues-voluntary-medical-device-correction-select-t-slim-x2</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-issues-voluntary-medical-device-correction-select-t-slim-x2</guid>
<pubDate>Thu, 07 Aug 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps</description>
</item>
<item>
<title>Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-second-200500272</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-second-200500272</guid>
<pubDate>Wed, 06 Aug 2025 20:05:00 GMT</pubDate>
<description>SAN DIEGO, August 06, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2025 and provided full year 2025 guidance.</description>
</item>
<item>
<title>Tandem Diabetes Care Announces Upcoming Conference Participation</title>
<link>https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-upcoming-conference-participation-2025-07-31</link>
<guid isPermaLink="true">https://6ix.com/company/tandem-diabetes-care-inc/news/tandem-diabetes-care-announces-upcoming-conference-participation-2025-07-31</guid>
<pubDate>Thu, 31 Jul 2025 04:00:00 GMT</pubDate>
<description>SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that</description>
</item>
</channel>
</rss>